Beacon Trust Co. raised its stake in CME Group Inc. (NASDAQ:CME) by 2.0% during the second quarter, Holdings Channel reports. The institutional investor owned 50,871 shares of the company’s stock after buying an additional 1,001 shares during the period. Beacon Trust Co.’s holdings in CME Group were worth $4,955,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC boosted its stake in CME Group by 86.8% in the second quarter. FMR LLC now owns 6,394,597 shares of the company’s stock worth $622,833,000 after buying an additional 2,971,686 shares during the period. Westfield Capital Management Co. LP bought a new stake in CME Group during the second quarter valued at about $93,330,000. Edgewood Management LLC raised its stake in CME Group by 20.3% in the second quarter. Edgewood Management LLC now owns 5,482,310 shares of the company’s stock valued at $533,977,000 after buying an additional 923,942 shares in the last quarter. Kleinwort Benson Investors Dublin Ltd bought a new stake in CME Group during the second quarter valued at about $80,125,000. Finally, Canada Pension Plan Investment Board raised its stake in CME Group by 421.5% in the second quarter. Canada Pension Plan Investment Board now owns 860,537 shares of the company’s stock valued at $83,816,000 after buying an additional 695,517 shares in the last quarter. Hedge funds and other institutional investors own 80.60% of the company’s stock.
Shares of CME Group Inc. (NASDAQ:CME) opened at 114.38 on Monday. The firm’s 50-day moving average price is $104.57 and its 200-day moving average price is $101.32. The stock has a market capitalization of $38.81 billion, a P/E ratio of 26.66 and a beta of 0.81. CME Group Inc. has a 12 month low of $81.87 and a 12 month high of $117.80.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 27th. The company reported $1.05 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.04 by $0.01. The business earned $842 million during the quarter, compared to analyst estimates of $855.94 million. CME Group had a return on equity of 6.90% and a net margin of 41.54%. The company’s revenue was down 1.0% on a year-over-year basis. During the same quarter last year, the business posted $1.02 EPS. On average, equities research analysts forecast that CME Group Inc. will post $4.35 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 28th. Investors of record on Friday, December 9th will be paid a $0.60 dividend. The ex-dividend date of this dividend is Wednesday, December 7th. This represents a $2.40 annualized dividend and a dividend yield of 2.10%. CME Group’s dividend payout ratio is presently 55.94%.
Several analysts have issued reports on the company. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $116.00 price target for the company in a report on Thursday, August 4th. RBC Capital Markets set a $92.00 price target on CME Group and gave the company a “sell” rating in a report on Friday, October 28th. Jefferies Group boosted their price target on CME Group from $112.00 to $118.00 and gave the company a “buy” rating in a report on Wednesday, August 31st. Royal Bank Of Canada cut their price target on CME Group from $97.00 to $92.00 and set an “underperform” rating for the company in a report on Friday, October 28th. Finally, Barclays PLC cut their price target on CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a report on Friday, July 29th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $102.89.
In related news, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, September 2nd. The stock was sold at an average price of $109.00, for a total value of $32,700.00. Following the sale, the director now directly owns 42,802 shares in the company, valued at approximately $4,665,418. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Kimberly S. Taylor sold 2,300 shares of CME Group stock in a transaction dated Tuesday, August 30th. The stock was sold at an average price of $107.16, for a total value of $246,468.00. Following the completion of the sale, the insider now owns 101,489 shares in the company, valued at $10,875,561.24. The disclosure for this sale can be found here. 0.61% of the stock is owned by corporate insiders.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.